USG-United Scientific Group proudly presents the "7th International Conference on Nursing Science & Practice (Nursing Science-2024)," set to take place from April 17-19, 2024, in Los Angeles, CA. This influential event brings together nurse practitioners, nurse anesthetists, clinical nurses, and more, alongside researchers, educators, students, and policymakers. With a focus on knowledge exchange, professional growth, and healthcare advancement, Nursing Science-2024 offers both in-person and virtual attendance options, ensuring broader accessibility. By fostering collaboration, sharing best practices, and showcasing healthcare innovations, the conference strengthens nursing's global impact and provides a platform for critical discussions on equitable healthcare. Join us to drive the conversation forward in 2024.

Read on unitedscientificgroup.org

The 5th Edition Excellence in Real World Evidence and Data Utilization Conference will provide insights to improve patient outcomes and treatment efficacy through the utilization of real-world data and evidence throughout the drug lifecycle.  Hear from leading industry experts from pharmaceuticals, biotech, and medical device companies with responsibilities with RWE and HEOR across diverse therapeutic expertise that address the interpretation of regulatory guidance, synthesize and model data and evidence, and determine value from the data.

Key Topics

• Rising Above the Noise: Basing Drug Price on Drug Value
• Analyzing RWE to Best Understand Your Patient Population: Diversity & Inclusion Strategies
• Integrating Data Sources for Optimal Success in Randomized Trials and Real World Evidence
• Navigating the Regulatory Guidelines and Guidance for Optimal Submissions, Approvals, and Outcomes
• Dissecting Causal Inference Utilized for Real World Evidence Generation
• Discussing Tokenization of Clinical Trials for (Long Term) Follow Up of Trial Subjects Using RWD.

Read on marcusevans.com

s clinical research in the oncology therapeutic area becomes increasingly complex, effectively capturing high-quality data across multiple endpoints becomes even more critical to a drug’s success. Many oncologic agents have cardiac toxicities, including depression of left ventricular function, QTc prolongation and elevation of blood pressure. Register for this webinar to learn about the intersection of oncology drug development and cardiac safety, and how this new area is changing the landscape for early-phase clinical trials. Cardio-oncology, an evolving subspecialty focused specifically on the detection and management of these risks, has become an essential consideration within any oncology development program. Additionally, with the growing emphasis on patient-focused drug development, recent regulatory guidelines now outline core patient-reported outcomes (PROs) that should be included in oncology clinical trials. Among these are self-reported symptomatic adverse events, with the new 2023 US Food and Drug Administration (FDA) draft guidance acknowledging the importance of utilizing this self-reported data to enhance the assessment of tolerability in early-phase dose optimization trials.

Read on xtalks.com

Dental Conferences: Meet and Join Hands with leading Dental Experts, Dentists and Scientists with their innovative ideas from USA, Europe, Middle East, Asia Pacific, and Africa at Dentists 2023 Conference at Rome, Italy happening on March 20-21, 2023

Read on dentists.dentistryconferences.com